Results 111 to 120 of about 5,648 (180)

Methotrexate-Associated Lymphoproliferative Disorders Characterized by a T-Cell Phenotype With Lung and Psoas Involvement: A Case Report. [PDF]

Case Rep Med
Arai K, Tokuyasu H, Sueda Y, Sakai H, Watase H, Yoshioka M, Naritomi Y, Esumi C, Yamasaki A.   +8 more
europepmc   +1 more source

Preclinical activity of brincidofovir in peripheral T-cell and NK/T-cell lymphoma. [PDF]

BMC Med
Chan JY, Lee ECY, Chai KXY, Lim BY, Li Z, Lee JY, Kannan B, Tay HY, Ko TK, Kok JS, Lim KS, Taib NABM, Huang D, Lim JQ, Hazama M, Fukushima K, Teh BT, Lim ST, Ong CK.   +18 more
europepmc   +1 more source

Beyond the Rash: Cutaneous Peripheral T-Cell Lymphoma as a Diagnostic Pitfall in Primary Care. [PDF]

Cureus
Hensley J, Calderon A, Martin BC, Kochi C, Suarez Parraga AR.   +4 more
europepmc   +1 more source

XPO1 inhibitor selinexor enhances the apoptotic effect of azacitidine in T-cell lymphoma with TET2/RHOA mutations via JAK3/STAT3 axis. [PDF]

Cell Commun Signal
Xu TT, Cai MC, Cheng S, Huang YH, Zhang QQ, Xu PP, Wang L, Qiu YR, Zhao WL.   +8 more
europepmc   +1 more source

Genome-epigenome crosstalk in T-cell lymphomas: from maps to mechanisms. [PDF]

Int J Hematol
Yamagishi M.
europepmc   +1 more source

Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working party. [PDF]

J Hematol Oncol
Shumilov E, Ngoya M, Berning P, Devillier R, Forcade E, Schroeder T, Kroschinsky F, Stelljes M, Valkova V, Kinsella F, Chevallier P, Olesen G, Mohty M, de Fontbrune FS, Wagner-Drouet E, Zeiser R, Herling M, Franke GN, López-Corral L, Ayuk F, Lenz G, Wulf G, Sureda A, Laurence A, Dreger P, Bazarbachi A, Schmitz N.   +26 more
europepmc   +1 more source

Epstein-barr virus-encoded small RNA incorporated prognostic model enables precision risk stratification and guides treatment decisions in peripheral t-cell lymphoma: a multicenter retrospective cohort. [PDF]

Ann Hematol
Chen ZT, Huang L, Guo HG, Lin CD, Jiang XM, Wei XJ, Chen FL, Liu SC, Zhang H, Liang ZL, Wang N, Zhang XD, Lin LE, Liu TB, Zhou JH, Peng ZG, Li WY.   +16 more
europepmc   +1 more source

USP1-TRAF2 axis-regulated mortalin stability mediates chemoresistance by disrupting calcium transport in peripheral T-cell lymphoma. [PDF]

Proc Natl Acad Sci U S A
Gui A, Yan Y, Jiang S, Chen F, Zhou X, Sun Q, Qiu S, Wu J, Li X, Zhang J, Liu J, Zhu S, Wang L, Liu W, Zuo J, Zhang Q, Yang L.   +16 more
europepmc   +1 more source

Personalized Immunotherapy for T Cell Lymphomas: From Immune Escape to Precision Therapeutics. [PDF]

J Pers Med
Casan JML, Ong XJ, van der Weyden C, Yannakou CK, Zhu J, D'Souza C, Neeson P, Prince HM.   +7 more
europepmc   +1 more source